Literature DB >> 16875781

Articulatory rehearsal in verbal working memory: a possible neurocognitive endophenotype that differentiates between schizophrenia and schizoaffective disorder.

Oliver Gruber1, Eva Gruber, Peter Falkai.   

Abstract

Recent fMRI studies have identified brain systems underlying different components of working memory in healthy individuals. The aim of this study was to compare the functional integrity of these neural networks in terms of behavioural performance in patients with schizophrenia, schizoaffective disorder and healthy controls. In order to detect specific working memory deficits based on dysfunctions of underlying brain circuits we used the same verbal and visuospatial Sternberg item-recognition tasks as in previous neuroimaging studies. Clinical and performance data from matched groups consisting of 14 subjects each were statistically analyzed. Schizophrenic patients exhibited pronounced impairments of both verbal and visuospatial working memory, whereas verbal working memory performance was preserved in schizoaffective patients. The findings provide first evidence that dysfunction of a brain system subserving articulatory rehearsal could represent a biological marker which differentiates between schizophrenia and schizoaffective disorder.

Entities:  

Mesh:

Year:  2006        PMID: 16875781     DOI: 10.1016/j.neulet.2006.06.062

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  17 in total

1.  Dynamic interactions between neural systems underlying different components of verbal working memory.

Authors:  O Gruber; T Müller; Peter Falkai
Journal:  J Neural Transm (Vienna)       Date:  2007-02-22       Impact factor: 3.575

Review 2.  Schizoaffective disorder: a review of current research themes and pharmacological management.

Authors:  Joshua T Kantrowitz; Leslie Citrome
Journal:  CNS Drugs       Date:  2011-04       Impact factor: 5.749

3.  Schizoaffective disorder - a possible MEG auditory evoked field biomarker.

Authors:  Martin Reite; Peter Teale; Dan Collins; Donald C Rojas
Journal:  Psychiatry Res       Date:  2010-05-21       Impact factor: 3.222

Review 4.  [From identification of neurofunctional systems to individualization of treatment for schizophrenic disorders].

Authors:  O Gruber; P Falkai
Journal:  Nervenarzt       Date:  2009-01       Impact factor: 1.214

5.  Neurophysiological Distinction between Schizophrenia and Schizoaffective Disorder.

Authors:  Daniel H Mathalon; Ralph E Hoffman; Todd D Watson; Ryan M Miller; Brian J Roach; Judith M Ford
Journal:  Front Hum Neurosci       Date:  2010-01-29       Impact factor: 3.169

Review 6.  [Working memory dysfunctions in psychiatric disorders].

Authors:  I Henseler; Oliver Gruber
Journal:  Nervenarzt       Date:  2007-09       Impact factor: 1.214

7.  Multimodal analyses identify linked functional and white matter abnormalities within the working memory network in schizophrenia.

Authors:  Gisela Sugranyes; Marinos Kyriakopoulos; Danai Dima; Jonathan O'Muircheartaigh; Richard Corrigall; Gabrielle Pendelbury; Daniel Hayes; Vince D Calhoun; Sophia Frangou
Journal:  Schizophr Res       Date:  2012-04-03       Impact factor: 4.939

8.  Genetic polymorphisms of 5-HTT and DAT but not COMT differentially affect verbal and visuospatial working memory functioning.

Authors:  David Zilles; Jobst Meyer; Thomas Schneider-Axmann; Savira Ekawardhani; Eva Gruber; Peter Falkai; Oliver Gruber
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-03-28       Impact factor: 5.270

9.  Evidence for anomalous network connectivity during working memory encoding in schizophrenia: an ICA based analysis.

Authors:  Shashwath A Meda; Michael C Stevens; Bradley S Folley; Vince D Calhoun; Godfrey D Pearlson
Journal:  PLoS One       Date:  2009-11-19       Impact factor: 3.240

10.  The DTNBP1 (dysbindin-1) gene variant rs2619522 is associated with variation of hippocampal and prefrontal grey matter volumes in humans.

Authors:  S Trost; B Platz; J Usher; H Scherk; T Wobrock; S Ekawardhani; J Meyer; W Reith; P Falkai; O Gruber
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-05-13       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.